Tag

Dea

All articles tagged with #dea

Fentanyl exposure hits NM first responders at deadly overdose scene
us-news3 days ago

Fentanyl exposure hits NM first responders at deadly overdose scene

First responders arriving at a Mountainair, NM home to investigate a possible overdose were exposed to fentanyl after discovering four unconscious people; two died at the scene and a third died after transport to the hospital, with the fourth surviving after Narcan. More than a dozen responders were quarantined due to exposure, and DEA lab analysis confirmed the presence of fentanyl, methamphetamine and para-fluorofentanyl at the scene. In total, 25 people were exposed. The investigation continues, with no immediate signs the drugs were manufactured at the home, and five dogs were quarantined.

DEA Expands Federal Registration for Medical Cannabis Firms Ahead of Schedule III Move
policy15 days ago

DEA Expands Federal Registration for Medical Cannabis Firms Ahead of Schedule III Move

DEA says it will roll out new registration forms for Medical Marijuana Manufacturer, Bulk Manufacturer, Analytical Lab, and Distributor to align with the DOJ’s phased move of marijuana from Schedule I to Schedule III. The current 60-day dispensary registration window ends June 26, and the new forms will be posted in coming weeks on the DEA Diversion Registration page. The applications will require details on licenses, security measures, ownership, suppliers, and access to controlled substances, and carry a nonrefundable $794 fee (PayPal now; other payment options to be added). The update is part of broader rescheduling actions, which include an expedited hearing process starting June 29; IRS guidance on taxes and ATF form updates are also anticipated as federal policy shifts on cannabis.

Federal Push Dismantles Open-Air Drug Market at Los Angeles' MacArthur Park
crime19 days ago

Federal Push Dismantles Open-Air Drug Market at Los Angeles' MacArthur Park

Eighteen defendants were arrested in a federal crackdown targeting MacArthur Park's open-air drug market, with authorities charging 25 people overall in a distribution scheme tied to the 18th Street Gang and others. About 18 kilograms of fentanyl were seized at a Calabasas stash location, and several suspects remain fugitives as the operation—led by the DEA with LAPD support—seeks to reclaim the park and surrounding area from trafficking, with potential federal prison terms up to life for the key figures.

Lawsuit Targets Federal Marijuana Rescheduling, Blocking DOJ Action
politics20 days ago

Lawsuit Targets Federal Marijuana Rescheduling, Blocking DOJ Action

Opponents SAM and the NDASA filed a DC Circuit lawsuit to overturn the DOJ’s cannabis rescheduling from Schedule I to III, arguing the action violates the Administrative Procedure Act and the CSA; the petition names the DOJ, the DEA, Acting Attorney General Todd Blanche, and DEA Administrator Terrance Cole, with Barr-linked Torridon Law representing the plaintiffs, as a broader administrative hearing on rescheduling looms. The filing comes amid ongoing political pushback and a House panel’s moves to block further federal steps on cannabis policy.

Euphoria S3E4: Cassie’s Glow-Up and Rue’s DEA Dilemma
tv22 days ago

Euphoria S3E4: Cassie’s Glow-Up and Rue’s DEA Dilemma

Recap of Euphoria season 3, episode 4: Cassie levels up with a Hollywood makeover and an OnlyFans boost to cover Nate’s $1 million debt, while Rue endures a tense DEA interrogation and contemplates turning in Laurie and Alamo; a twist has Rue identify Faye as Laurie’s getaway driver, and Lexi enlists Jules to paint a risqué backdrop for her show as the episode’s chaotic energy unfolds.

Partial cannabis rescheduling fuels federal policy confusion
politics26 days ago

Partial cannabis rescheduling fuels federal policy confusion

The Trump administration moved state-licensed medical cannabis products and FDA-approved cannabis products from Schedule I to Schedule III, a partial rescheduling that doesn’t fully normalize cannabis at the federal level. Experts say this is not a broad reclassification and hinges on future FDA decisions, leaving implementation unclear and raising questions about protections for patients, housing and employment, and equity for minority entrepreneurs. A June 29 DEA hearing on rescheduling adds to the uncertainty amid ongoing debate about alignment with the UN Single Convention and overall public support for full legalization.

DEA Opens Registration Portal as Medical Cannabis Gains Federal Protections
politics28 days ago

DEA Opens Registration Portal as Medical Cannabis Gains Federal Protections

The DEA will begin accepting applications this week for federal protections under the cannabis rescheduling plan, launching a Medical Marijuana Dispensary Registration Portal as marijuana moves from Schedule I to Schedule III in phases. Applicants must provide extensive details on licensing, security, suppliers, and personnel, and pay a $794 fee (currently via PayPal). The process accompanies an expedited administrative hearing to consider broader rescheduling, with forthcoming tax guidance from Treasury/IRS and White House framing the move as broadly popular and beneficial for patients and farmers.

US set to reclassify marijuana amid Axios briefing
us-politics1 month ago

US set to reclassify marijuana amid Axios briefing

The Biden-era administration is reportedly moving to reclassify marijuana as early as Wednesday, per Axios, which would place the drug among less dangerous substances and could lower tax burdens and ease funding for cannabis companies. The decision rests with the DEA and had not been officially commented on by the Justice Department at the time; markets reacted as cannabis stocks rose on the report, signaling a potential major shift in federal marijuana policy.

Trump downgrades federal classification of state-licensed medical marijuana
politics1 month ago

Trump downgrades federal classification of state-licensed medical marijuana

President Trump's acting attorney general signed an order moving state-licensed medical marijuana from Schedule I to Schedule III, shifting how it's regulated without legalizing it nationwide; the measure eases research, lets licensed producers deduct business expenses on federal taxes, and creates an expedited DEA registration path for state programs, while signaling a broader reclassification process with a late-June hearing. Critics and advocates react differently, highlighting a major policy shift after decades of federal prohibition and a patchwork of state laws.

DOJ Reclassifies FDA-Approved Marijuana to Schedule III, Moves to Broaden Federal Rescheduling
politics1 month ago

DOJ Reclassifies FDA-Approved Marijuana to Schedule III, Moves to Broaden Federal Rescheduling

Following President Trump’s December 2025 executive order, the Justice Department and DEA placed FDA-approved marijuana products and state-licensed medicinal marijuana in Schedule III under the Controlled Substances Act and announced an expedited administrative hearing beginning June 29, 2026 to consider broader rescheduling from Schedule I to Schedule III, with procedural updates to speed rulemaking while maintaining federal controls.

Trump admin eyes reclassifying marijuana to Schedule II to boost medical research
politics1 month ago

Trump admin eyes reclassifying marijuana to Schedule II to boost medical research

The Trump administration is preparing to move marijuana from Schedule I to Schedule II, a change that would allow more medical research by the DEA and scientists. The plan would begin with an administrative hearing, and Trump has said the move is not federal decriminalization. Biden-era guidance had suggested Schedule III as an alternative, and polls show growing public support for loosening restrictions, though current penalties and federal status would largely remain unchanged.

Morales mists over Bolivia as former president vanishes amid arrest warrant
world3 months ago

Morales mists over Bolivia as former president vanishes amid arrest warrant

Former Bolivian president Evo Morales, under an arrest warrant for alleged human trafficking, has vanished from public view for weeks after criticizing the U.S. attack on Venezuela. While supporters say he’s ill with dengue, officials say he remains in the Chapare region, fueling theories about his whereabouts as Bolivia’s government under Rodrigo Paz Pereira seeks closer U.S. ties and a possible return of the DEA, with a tense backdrop ahead of the 2025 presidential vote.